Company intelligence / Profile preview

Xeno Diagnostics

Indianapolis, Indiana, United Statesxenodiagnostics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Xeno Diagnostics specializes in in vitro evaluation of immune responses to potential transplant tissues and novel compounds using assays such as Mixed Lymphocyte Reactions (MLR), cytotoxicity assays (CDC/ADCC), cytokine release assays, receptor occupancy assays, and immunoglobulin quantification. The company supports translational research by providing reagents and testing services for preclinical drug development with an emphasis on xeno-transplantation models.

Modalities: Cell therapy (evaluation and testing)Biologic (testing of engineered cells, tissues, and biologics)
Industry: Contract Research Organization

Beyond the preview

Go deeper on Xeno Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xeno Diagnostics.

Explore the full profile